Oramed Pharmaceuticals Inc ORMP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:10 AM EST
8.68quote price arrow down-0.12 (-1.36%)
Volume
270
Close
8.80quote price arrow down-0.24 (-2.65%)
Volume
334,635
52 week range
2.40 - 11.71

...

Loading . . .

KEY STATS

  • Open8.81
  • Day High9.34
  • Day Low8.77
  • Prev Close8.80
  • 52 Week High11.71
  • 52 Week High Date02/16/21
  • 52 Week Low2.40
  • 52 Week Low Date10/29/20
  • Market Cap234.61M
  • Shares Out26.66M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • 1 Year % Change117.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.67
  • P/E (TTM)-13.20
  • Fwd P/E (NTM)-12.31
  • EBITDA (MRQ)-15.146M
  • ROE (MRQ)-64.08%
  • Revenue (MRQ)2.71M
  • Gross Margin (MRQ)75.13%
  • Net Margin (MRQ)-536.46%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date04/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Oramed Pharmaceuticals Inc News

There is no recent news for this security.

Latest ORMP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Oramed Pharmaceuticals Inc. is a pharmaceutical company. It is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Its pipeline products are ORMD-0801 Type 1, ORM-0801 Type 2 and ORMD-0901. Its flagship product, ORMD-0801, is an orally ingestible insulin capsule. It is anticipated...
Kevin Rakin
Chairman
Nadav Kidron
Chief Executive Officer
Joshua Hexter
Chief Operating Officer
Avraham Gabay CPA
Chief Financial Officer
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
New York, NY
10036
United States